WITHDRAWN: AAV-Mediated CAR-T therapy eradicate HIV reservoirs with augmented safety and persistence
Nawaz, W.; Ihsan, A. U.; Rehan, M.; Masroori, N.; Shalak, A. C.; Deyan, C.; Ur-Rehman, U.
Show abstract
Withdrawal statementThe authors have withdrawn their manuscript because additional studies are required to fully support the conclusions. These experiments are planned and a revision will be submitted in the future. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evolving Membrane-Associated Accessory Protein Variants for Improved Adeno-Associated Virus Production 95%
- Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations 94%
- Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 94%
Similar papers in this journal
- CRISPRCas9-mediated gene disruption of endogenous co-receptors confers broad resistance to HIV-1 in human primary cells and humanized mice 96%
- Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus 95%
- Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient And Long-Term Transgene Expression In The Central Nervous System 94%
Similar papers in this journal
Similar papers in this journal
- AAVone: A Cost-Effective, Single-Plasmid Solution for Efficient AAV Production with Reduced DNA Impurities 94%
- Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy 92%
- Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells 92%
Similar papers in this journal
- Targeting PD-1+ T-cells with Chimeric Antigen Receptors to reduce the HIV Reservoir 95%
- Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B 93%
- A Safe Harbor-Targeted CRISPR/Cas9 Homology Independent Targeted Integration (HITI) System for Multi-Modality Reporter Gene-Based Cell Tracking 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.